Novartis y...el Offshoring en Investigación clínica.

Click sobre imagen para ampliar.

...the Swiss company was already conducting nearly two-thirds of its clinical trials in emerging markets by 2011 (see Exhibit)

Tomado de: booz&Co./Pharma Emerging Markets 2.0

Ver también:
Más Novartis y offshoring